This is partially corroborated by data showing that NF-κB inhibition reduces specific cytokines in RA FLS, suggesting that anti-vimentin antibodies may specifically inhibit NF-κB pathways [59]. This evidence concerns the gene VIM and rheumatoid arthritis.